Endothelial Cell Transcriptomics Reveal Activation of Ribosomal-related Pathways in Chronic Thromboembolic Pulmonary Hypertension

Study limitation reported by the research below: “This is a mechanistic/translational study without a clinical outcomes endpoint; the therapeutic implications of targeting the ribosomal-translational axis are speculative at this stage.”